Skip to main content
Log in

Eltroxin: ADR reports increase following excipient change

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Danish Medicines Agency.Eltroxin (Rm) status. Nyt Om Bivirkninger: [2 pages], 18 Aug 2010. Available from: URL: http://www.dkma.dk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eltroxin: ADR reports increase following excipient change. React. Wkly. 1318, 6 (2010). https://doi.org/10.2165/00128415-201013180-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013180-00012

Keywords

Navigation